| The role of inflammatory cytokines in the pathogenesis of colorectal carcinoma—recent findings and review J Borowczak, K Szczerbowski, M Maniewski, A Kowalewski, ... Biomedicines 10 (7), 1670, 2022 | 29 | 2022 |
| CDK9 inhibitors in multiple myeloma: a review of progress and perspectives J Borowczak, K Szczerbowski, N Ahmadi, Ł Szylberg Medical oncology 39 (4), 39, 2022 | 20 | 2022 |
| CDK9: therapeutic perspective in HCC therapy J Borowczak, K Szczerbowski, E Stec, D Grzanka, Ł Szylberg Current Cancer Drug Targets 20 (5), 318-324, 2020 | 11 | 2020 |
| The prognostic role of CDK9 in bladder cancer J Borowczak, K Szczerbowski, M Maniewski, M Zdrenka, P Słupski, ... Cancers 14 (6), 1492, 2022 | 8 | 2022 |
| TOLLIP protein expression predicts unfavorable outcome in renal cell carcinoma A Kowalewski, D Jaworski, J Borowczak, M Maniewski, K Szczerbowski, ... International Journal of Molecular Sciences 23 (23), 14702, 2022 | 3 | 2022 |
| Diagnostic biopsy does not accurately reflect the PD-L1 expression in triple-negative breast cancer M Zdrenka, A Kowalewski, J Borowczak, J Łysik-Miśkurka, H Andrusewicz, ... Clinical and Experimental Medicine 23 (8), 5121-5127, 2023 | 1 | 2023 |
| The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma J Borowczak, K Szczerbowski, M Maniewski, M Zdrenka, P Słupski, ... Clinical and Translational Oncology 25 (3), 830-840, 2023 | 1 | 2023 |
| Assessment of immunomodulation and regulation of cell cycle in epithelium and stroma after Cidofovir injection in patients with recurrent respiratory papillomatosis—Pilot study P Solarz, M Bodnar, J Czech, H Mackiewicz–Nartowicz, A Sinkiewicz, ... Journal of Medical Virology 95 (1), e28303, 2023 | 1 | 2023 |
| Lymphovascular Invasion in Gastric Cancer—Important or Unimportant? M Janiczek-Polewska, J Borowczak, Ł Szylberg, I Jagiełło, P Poter, ... Preprints, 2024 | | 2024 |
| Atypical Presentation of Bronchogenic Cyst in the Retroperitoneal Space K Gostomczyk, J Borowczak, M Zdrenka, Ł Szylberg Cureus 16 (2), 2024 | | 2024 |
| Refining PD-1/PD-L1 assessment for biomarker-guided immunotherapy: A review M Zdrenka, A Kowalewski, N Ahmadi, RU Sadiqi, Ł Chmura, J Borowczak, ... Biomolecules and Biomedicine 24 (1), 14, 2024 | | 2024 |
| Flow cytometry in the detection of circulating tumor cells in neoplastic effusions K Gostomczyk, E Łukaszewska, J Borowczak, A Bator, M Zdrenka, ... Clinica Chimica Acta 552, 117651, 2024 | | 2024 |
| Targeting circulating tumor cells to prevent metastases K Gostomczyk, MDM Marsool, H Tayyab, A Pandey, J Borowczak, ... Human Cell 37 (1), 101-120, 2024 | | 2024 |
| Mechanisms of SARS-CoV-2 Placental Transmission K Gostomczyk, J Borowczak, M Siekielska-Domanowska, K Szczerbowski, ... Archivum Immunologiae et Therapiae Experimentalis 72 (1), 1-10, 2023 | | 2023 |
| Enhanced TOLLIP expression confers poor prognosis in renal cell carcinoma A Kowalewski, D Jaworski, J Borowczak, M Maniewski, P Antosik, ... VIRCHOWS ARCHIV 481 (SUPPL 1), S169-S170, 2022 | | 2022 |
| Current Challenges in Targeting Tumor Desmoplasia to Improve the Efficacy of Immunotherapy A Kasperska, J Borowczak, K Szczerbowski, E Stec, N Ahmadi, Ł Szylber Current Cancer Drug Targets 21 (11), 919-931, 2021 | | 2021 |
Łukasz Szylberg1. Department of Tumor Pathology and Pathomorphology, Oncology Center, Bydgoszcz, Poland 2. Chair of在 cm.umk.pl 的电子邮件经过验证
